Converge Bio brings GenAI to drug discovery
New company in Tel Aviv builds large language models that accelerate research and remove guesswork for biotech and pharma businesses.
New company in Tel Aviv builds large language models that accelerate research and remove guesswork for biotech and pharma businesses.
Edge Medical Ventures approaches large global medical-device makers with one simple question: ‘What do you need?’
AI firms now account for 30% of the nation’s 7,000-plus startups but are bringing in 47% of all investment.
Innoventric’s Trillium, now in clinical trials, is implanted in a 10-minute procedure under sedation to treat a leak in the tricuspid valve.
D-ID’s Video Translate software enables anyone creating online content to break through language barriers and reach a global audience.
Israeli researchers believe they’ve found a way of identifying and removing senescent cells by adapting a new generation of cancer treatments.
Fermata monitors crops to automatically detect problems; yieldsApp translates that data into tailored recommendations.
New machine-learning approach can help identify fake news sources needing further investigation, quickly and cheaply.
US-Israel Business Alliance launches custom promotional merchandise website seeking to support struggling Israeli businesses.
Northern residents can now fly to Eilat and Cyprus from a much closer international point of departure than Tel Aviv’s Ben-Gurion Airport.
In the millennia-old quest to find a commercial use for olive-mill waste, PhenOlive flour may have the answer for mills, farmers, and the environment.
Researchers say antibiotics given in infancy can disrupt development of the microbiome, resulting in increased levels of aggression later in life.
By applying knowledge of mid-flight refueling in airplanes to trains, two entrepreneurs have found a way to double the number of trains running on a network, and make them faster.
When Afeka Academic College of Engineering asked managers to rank the most desirable job skills, the ability to work with AI programs came out on top.
A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup developing a drug combo that aims to slow progression of ALS and other neurodegenerative diseases.